20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Phibro Animal Health Corporation (PAHC) operates in the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry and is headquartered in Teaneck, United States with about 2,605 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2026-06-30, PAHC reported $1.5B in revenue and $100M in net income.
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products.
Interactive charts & full statements → Open the PAHC valuation workbench →
| Income statement | TTM → 2026-06-30 | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 | 2016-06-30 | 2015-06-30 | 2014-06-30 | 2013-06-30 | 2012-06-30 | 2011-06-30 | 2010-06-30 | 2009-06-30 | 2008-06-30 | 2007-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $1.5B | $1.5B | $1.3B | $1.0B | $978M | $942M | $833M | $800M | $828M | $820M | $764M | $752M | $749M | $692M | $653M | $654M | $618M | $594M | $537M | $511M | $453M |
| Gross Profit | $512M | $512M | $400M | $313M | $298M | $285M | $271M | $257M | $265M | $267M | $248M | $239M | $236M | $208M | $179M | $164M | $147M | $155M | $130M | $122M | $111M |
| Gross Margin % | 33.7% | 33.7% | 30.9% | 30.8% | 30.5% | 30.3% | 32.6% | 32.1% | 32.0% | 32.6% | 32.5% | 31.8% | 31.6% | 30.0% | 27.4% | 25.1% | 23.7% | 26.0% | 24.1% | 23.8% | 24.6% |
| Operating Income (EBIT) | $198M | $198M | $110M | $53M | $72M | $79M | $75M | $69M | $73M | $99M | $98M | $86M | $88M | $64M | $57M | $49M | $41M | $53M | $41M | $29M | $21M |
| Operating Margin % | 13.1% | 13.1% | 8.5% | 5.2% | 7.3% | 8.4% | 9.0% | 8.6% | 8.8% | 12.1% | 12.8% | 11.4% | 11.7% | 9.2% | 8.7% | 7.5% | 6.7% | 8.9% | 7.7% | 5.7% | 4.7% |
| Net Income | $100M | $100M | $48M | $2M | $33M | $49M | $54M | $34M | $55M | $65M | $65M | $83M | $60M | ($3M) | $25M | $7M | ($13M) | $42M | ($8M) | $2M | ($7M) |
| Net Margin % | 6.6% | 6.6% | 3.7% | 0.2% | 3.3% | 5.2% | 6.5% | 4.2% | 6.6% | 7.9% | 8.5% | 11.0% | 8.1% | -0.4% | 3.8% | 1.1% | -2.1% | 7.1% | -1.6% | 0.4% | -1.5% |
| EBITDA | $236M | $236M | $147M | $69M | $106M | $117M | $110M | $102M | $113M | $126M | $124M | $117M | $115M | $61M | $73M | $66M | $43M | $13M | ($48M) | ($22M) | ($23M) |
| Earnings Per Share (EPS) | $2.43 | $2.43 | $1.19 | $0.06 | $0.81 | $1.21 | $1.34 | $0.83 | $1.35 | $1.61 | $1.61 | $2.07 | $1.51 | $-0.10 | $0.82 | $0.23 | $-0.42 | $1.09 | $-0.21 | $0.06 | $-0.17 |
| Shares Outstanding (M) | 41M | 41M | 41M | 41M | 41M | 40M | 40M | 40M | 41M | 40M | 40M | 40M | 40M | 32M | 30M | 31M | 30M | 39M | 39M | 39M | 39M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $397M | $384M | $374M | $364M | $379M | $348M | $309M | $260M |
| Gross Profit | $134M | $125M | $133M | $120M | $110M | $105M | $102M | $83M |
| Gross Margin % | 33.9% | 32.6% | 35.5% | 32.9% | 29.0% | 30.1% | 32.9% | 32.1% |
| Operating Income (EBIT) | $48M | $48M | $54M | $48M | $34M | $34M | $26M | $18M |
| Operating Margin % | 12.1% | 12.5% | 14.5% | 13.2% | 8.9% | 9.6% | 8.3% | 6.8% |
| Net Income | $22M | $24M | $27M | $27M | $17M | $21M | $3M | $7M |
| Net Margin % | 5.5% | 6.3% | 7.3% | 7.3% | 4.5% | 6.0% | 1.0% | 2.7% |
| EBITDA | $56M | $56M | $62M | $63M | $45M | $51M | $26M | $27M |
| Earnings Per Share (EPS) | $0.53 | $0.59 | $0.67 | $0.65 | $0.42 | $0.51 | $0.08 | $0.17 |
| Shares Outstanding (M) | 41M | 41M | 41M | 41M | 41M | 41M | 41M | 41M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 | 2016-06-30 | 2015-06-30 | 2014-06-30 | 2013-06-30 | 2012-06-30 | 2011-06-30 | 2009-06-30 | 2008-06-30 | 2007-06-30 | 2006-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $69M | $69M | $80M | $88M | $13M | $32M | $48M | $59M | $47M | $70M | $98M | $37M | $69M | ($1M) | $0M | $32M | ($5M) | $40M | — | ($5M) | $1M |
| Capital Expenditures (CapEx) | $59M | $59M | $38M | $41M | $52M | $37M | $29M | $34M | $30M | $19M | $21M | $36M | $20M | $20M | $20M | $15M | $22M | $18M | $20M | $11M | $15M |
| Free Cash Flow (FCF) | $10M | $10M | $42M | $46M | ($38M) | ($5M) | $19M | $25M | $17M | $51M | $78M | $1M | $49M | ($21M) | ($20M) | $17M | ($26M) | $22M | — | ($15M) | ($14M) |
| FCF Margin % | 0.7% | 0.7% | 3.2% | 4.6% | -3.9% | -0.6% | 2.3% | 3.2% | 2.1% | 6.3% | 10.1% | 0.1% | 6.5% | -3.0% | -3.0% | 2.6% | -4.3% | 4.2% | — | -3.4% | — |
| Dividends Paid | $19M | $19M | $19M | $19M | $19M | $19M | $19M | $19M | $19M | $16M | $16M | $16M | $16M | $25M | $3M | — | $50M | — | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $24M | $16M | $19M | $9M | $21M | $43M | $3M | $13M |
| Capital Expenditures (CapEx) | $19M | $15M | $11M | $14M | $13M | $8M | $8M | $10M |
| Free Cash Flow (FCF) | $5M | $1M | $8M | ($5M) | $8M | $35M | ($5M) | $3M |
| FCF Margin % | 1.3% | 0.2% | 2.2% | -1.2% | 2.1% | 10.2% | -1.5% | 1.2% |
| Dividends Paid | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 | 2020-06-30 | 2019-06-30 | 2018-06-30 | 2017-06-30 | 2016-06-30 | 2015-06-30 | 2014-06-30 | 2013-06-30 | 2012-06-30 | 2009-06-30 | 2008-06-30 | 2007-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.5B | $1.5B | $1.4B | $982M | $971M | $932M | $841M | $784M | $727M | $672M | $623M | $610M | $493M | $472M | $474M | $441M | $362M | $325M | $272M |
| Cash & Cash Equivalents | $61M | $61M | $68M | $71M | $41M | $74M | $50M | $36M | $58M | $29M | $56M | $34M | $29M | $12M | $27M | $54M | $14M | $7M | $12M |
| Total Liabilities | $1.1B | $1.1B | $1.1B | $726M | $689M | $669M | $603M | $596M | $511M | $487M | $472M | $520M | $464M | $457M | $543M | $529M | $416M | $363M | $360M |
| Total Debt (Short + Long-Term) | $743M | $743M | $728M | $496M | $481M | $439M | $399M | $393M | $109M | $83M | $71M | $72M | $6M | $289M | $366M | $350M | $289M | $247M | $249M |
| Total Shareholders' Equity | $385M | $385M | $286M | $257M | $283M | $262M | $239M | $188M | $216M | $185M | $151M | $90M | $30M | $15M | ($69M) | ($88M) | ($54M) | ($38M) | ($88M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PAHC viewer.
About TickerBase · Data methodology & sources · Privacy · Terms